Skip to content
OpenCapital
Get started

Incyte INCY Europe — Total revenues

Other geography segments

Other countries
$8.78M+222%

Similar metrics at other companies

Exelixis logo
EXELEurope — Total revenues
$39.57M+21.0%
Gilead Sciences logo
GILDEurope — Total revenues
$1.14B+5.5%
Moderna logo
MRNAEurope — Total Revenue
$13.25M-91.1%
Mirion Technologies logo
MIREurope — Total revenues
$77.9M+18.9%
Fortrea Holdings Inc. logo
FTREEurope — Revenue
$213.9M+6.8%
IAR
IARTEurope — Total Revenues
$39.96M+13.1%

Other financials

Income statement

See full
Revenue$1.3B+20.9%
Gross profit$1.2B+19.2%
Operating income$301.1M+46.8%
Net income$303.3M+91.7%
EPS (diluted)$1.47+83.7%

Balance sheet

See full
Cash & equivalents$3.5B+78.2%
Total debt$39.4M-8.6%
Total equity$5.6B+53.3%
Total assets$7.3B+27.7%

Cash flow

See full
Operating cash flow$369.4M+38.8%
CapEx$1.6M-43.5%
Free cash flow$367.7M+39.7%

Valuation

See full
Market cap$23.32B+78.0%
Enterprise value$19.89B+77.9%
P/E16.3×+1.2×
P/S4.4×+1.5×

Profitability

See full
Gross margin92.5%-0.2pp
Operating margin30%+26.1pp
Net margin26.7%+26.2pp
FCF margin28.2%+19.7pp

Returns & leverage

See full
Return on equity30.8%+30.4pp
Debt / equity0×0.0×
Current ratio3.7×+1.6×

Where this comes from

Reported directly by Incyte in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Incyte’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Incyte's europe — total revenues.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Incyte's europe — total revenues?
Incyte (INCY) reported europe — total revenues of $92.43M in Q1 2026.
How has Incyte's europe — total revenues changed year-over-year?
Incyte's europe — total revenues increased by 34.7% year-over-year, from $68.61M to $92.43M.
What is the long-term trend for Incyte's europe — total revenues?
Over 4 years (2021 to 2025), Incyte's europe — total revenues has grown at a 27.1% compound annual growth rate (CAGR), from $124.1M to $323.73M.
What does europe — total revenues mean?
This metric represents the total gross revenue generated from the sale of pharmaceutical products and licensing arrangements within the European geographic segment. It reflects the commercial success and market penetration of the company's oncology and dermatology portfolio in this specific region. This figure is a primary indicator of regional growth and the effectiveness of local distribution and partnership strategies.